Health Officials Warn of Meningitis Outbreak Risk Among Young

By the Editorial Team · Friday, October 2, 2026

UK health authorities are urging Year 13 students and university entrants under 25 to get the meningitis B vaccine following recent deaths and outbreaks linked to the disease. With vaccine uptake still low, officials warn that widespread immunization is essential to prevent further cases and protect vulnerable young people from severe complications.

Health authorities in the United Kingdom are urging young people to receive the meningitis B vaccine amid concerns over low uptake and the risk of further outbreaks. The vaccination campaign was launched following a meningitis outbreak that began in Kent in March, which resulted in the deaths of two young individuals. A third death linked to the same strain was also reported earlier in the year.

The UK Health Security Agency (UKHSA) emphasized that similar outbreaks remain a risk and encouraged those eligible to receive the vaccine promptly. The current vaccination effort targets Year 13 pupils, typically aged 17 and 18, and individuals under 25 who are starting university this autumn. The vaccine is being offered through pharmacies, with a schedule of two doses administered 28 days apart.

Despite the urgency, uptake has been relatively low. By September 20, only 26.6 percent of eligible Year 13 students had received the first dose, totaling 212,549 vaccinations out of 799,840 students invited. Health officials noted that coverage is gradually increasing but expressed concern about the large number remaining unprotected.

University students are considered particularly vulnerable due to social mixing patterns associated with campus life. Research cited by the UKHSA indicates that first-year university students face approximately seven times the risk of contracting meningitis B compared to their peers who do not attend university.

Dr. Sharif Ismail, a consultant epidemiologist with the UKHSA, highlighted the severity of meningitis B, noting that survivors may endure lifelong health complications. He also pointed to genomics research demonstrating how new and rapidly spreading strains of meningitis B can emerge unexpectedly, underscoring the unpredictability of future outbreaks.

The vaccination programme is set to continue until March 31, 2027. Data indicate that the meningitis B vaccine offers strong protection for at least five years after completion of the two-dose regimen. Eligible individuals can book appointments on the NHS website to receive the vaccine.

Health officials maintain that widespread vaccination is critical to preventing repeat outbreaks and reducing the impact of this potentially fatal disease among young populations.

This article was reported by synthesizing coverage from multiple independent news outlets to present a balanced, unbiased account. Read about our editorial standards. Spotted an error? Let us know.